Eledon Pharmaceuticals, Inc. (ELDN)

Eledon Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	22.81	20.55	4.61	56.41	84.83
Short-Term Investments	110.53	119.63	46.49	-	-
Cash & Short-Term Investments	133.34	140.18	51.1	56.41	84.83
Cash Growth	-4.88%	174.31%	-9.41%	-33.51%	-25.71%
Other Current Assets	2.35	3.55	5.03	3.11	3.51
Total Current Assets	135.69	143.73	56.13	59.52	88.35
Net Property, Plant & Equipment	0.61	0.93	0.37	0.74	0.77
Other Intangible Assets	32.39	32.39	32.39	32.39	32.39
Goodwill	-	-	-	-	48.65
Other Long-Term Assets	0.32	0.36	0.19	0.15	0.4
Total Assets	169.01	177.41	89.07	92.79	170.55
Accounts Payable	3.63	5.83	0.97	2.2	1.81
Current Portion of Leases	0.36	0.31	0.38	0.36	0.37
Other Current Liabilities	14.36	5.43	2.55	3.91	2.22
Total Current Liabilities	18.34	11.58	3.9	6.48	4.4
Long-Term Leases	0.28	0.64	-	0.38	0.4
Other Long-Term Liabilities	13.6	47.05	77.96	1.75	1.75
Total Long-Term Liabilities	13.89	47.69	77.96	2.14	2.15
Total Liabilities	32.23	59.27	81.86	8.61	6.55
Common Stock	0.08	0.06	0.02	0.01	0.01
Additional Paid-in Capital	482.19	417.95	270.89	-	278.88
Accumulated Other Comprehensive Income	0.02	0.03	-	-	-
Retained Earnings	-401.2	-355.59	-319.4	-202.87	-114.9
Total Common Shareholders' Equity	81.09	62.45	-48.49	-202.85	164
Minority Interest	55.69	55.69	55.69	-	-
Shareholders' Equity	136.78	118.14	7.21	-202.85	164
Total Liabilities & Equity	169.01	177.41	89.07	92.79	170.55
Total Debt	0.64	0.95	0.38	0.75	0.77
Net Cash (Debt)	132.7	139.22	50.72	55.66	84.06
Net Cash Growth	-4.69%	174.50%	-8.88%	-33.78%	-26.29%
Net Cash Per Share	1.62	2.87	2.06	3.90	5.67
Book Value	81.09	62.45	-48.49	-202.85	164
Book Value Per Share	0.99	1.29	-1.97	-14.20	11.07
Tangible Book Value	48.7	30.06	-80.87	-235.24	82.96
Tangible Book Value Per Share	0.60	0.62	-3.28	-16.47	5.60

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q